Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-20

Clinical Trial Update: Lamictal As Add on Treatment in Mixed States of Bipolar Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Lamictal as an add-on treatment for mixed states in bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LAMICTAL (LAMOTRIGINE)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED